Cure My Disease

Don't miss your cure!

 Log in / Sign up

What makes a hospital Low-Resource? global panel seeks a common answer

NCT ID NCT07826819

Knowledge-focused Sponsor: University Clinical Centre of Republic of Srpska Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Sep 17, 2026 · Last updated Sep 18, 2026 · Updated 1 time

Summary

Researchers are running an international Delphi study to build agreement on what 'low-resource setting' means in acute and critical care. Between 40 and 50 panelists from all inhabited continents, including people from low-resource settings and patient representatives, rate proposed statements over several anonymous rounds. The goal is a practical framework that describes resource limits across countries and within them, and to decide whether the term itself should stay or change.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

What this could lead to
If the panel reaches agreement, researchers could gain a shared definition of low-resource settings, which may make studies easier to compare and help tailor care to local conditions.
What could go wrong
Consensus among experts does not guarantee that the definition will fit every hospital or country, and the panel's views may not reflect all frontline realities. The framework may need testing before it changes how research is done.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 50 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Feb 2027

An estimate. Start dates often move.

Expected to finish

Feb 2028

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

The study population will comprise an international and multidisciplinary panel of healthcare professionals, researchers, policymakers, health-system experts, patient representatives, and other relevant stakeholders with knowledge or experience related to healthcare delivery and resource limitations. Participants will be recruited from different geographic regions, professional backgrounds, healthcare settings, and national income categories to ensure broad representation. Particular attention will be given to adequate representation of participants working in or having direct experience with low-resource settings.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: Adults aged 18 years or older. Healthcare professionals, researchers, policymakers, health system experts, patient representatives, or other stakeholders with relevant knowledge or experience related to healthcare delivery, critical care, global health, health systems, or resource-limited healthcare environments. Ability to read and understand English. Willingness to provide informed consent and participate in the Delphi process. Access to the internet and ability to complete electronic questionnaires. - Exclusion Criteria: Individuals younger than 18 years. Individuals without relevant professional, research, policy, health-system, or lived experience related to the study topic. Inability to understand the study information or complete the questionnaires in English. Refusal or inability to provide informed consent. Failure to complete the initial Delphi questionnaire round. \-

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Acute care medical are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Acute care medical Consensus Critical care Delphi study Global health Health systems Resource-limited setting

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • University Clinical Centre of the Republic of Srpska

    Banja Luka, The Repblic of Srpska, 78000, Bosnia and Herzegovina

More trials for these conditions

Other studies related to the condition(s) this trial covers.